• Dexcom One Transmitter to be added to March 2023 Drug Tariff

    Following representations from PSNC and Dexcom International Ltd, the Department of Health of Social Care (DHSC) has confirmed that the Dexcom One Transmitter will be added to Part IXA of the March 2023 Drug Tariff. Previously, patients were advised to obtain the free-of-charge Dexcom One transmitters directly from the pharmacies, without a prescription, as the original Drug Tariff application

    Read more
  • NMS: Voluntary quarterly data returns

    NHS England is asking community pharmacy contractors to voluntarily submit New Medicine Service (NMS) quarterly summary data to the NHS Business Services Authority (NHSBSA) for Quarter 3 (Q3) 2022/23. The mandatory requirement to submit this data has been suspended since 2020, due to the COVID-19 pandemic. NHS England want to re-start collection of the quarterly

    Read more
  • Reminder: National audit 2022/23 – valproate

    By 31st March 2023, all community pharmacy contractors must have completed the 2022/23 national clinical audit on valproate, over a six-week consecutive period.  The audit aims to reduce the potential harm caused by taking valproate during pregnancy. For contractors who have not yet commenced the audit, the last day on which you can start the

    Read more
  • NHS Digital merged into NHS England

    From 1st February 2023, NHS Digital teams and responsibilities have been absorbed into NHS England. This change follows a review which looked into how digital transformation could occur across the NHS in line with the objectives of the NHS Long Term Plan and a subsequent decision that NHS Digital would be merged into NHS England.

    Read more
  • Medicine Supply Notification: Bezafibrate (Bezalip® ) 200mg tablets

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Bezafibrate (Bezalip® ) 200mg tablets. MSN/2023/012 Tier 2 – medium impact Date of issue 6th February 2023 Bezafibrate (Bezalip®) 200mg tablets are out of stock until 20th March 2023. Alternative bezafibrate products remain available. Alternative fibrates remain available. A copy of

    Read more
  • NHS Prescription Services ‘Hints & Tips’ – Issue 50

    NHS Prescription Services produces a quarterly newsletter called “Hints & Tips for dispensing contractors”. The latest edition (Issue 50) contains some useful information and advice on: NHS England and Wales Drug Tariff OnlineHypromellose 0.3% eye drops – Drugs changing to AppliancesDisallowed itemsEndorsing SSPs To view current and previous issues of Hints & Tips click here. The

    Read more
  • PQS: Declaration window is open

    The declaration window for the Pharmacy Quality Scheme (PQS) 2022/23 is now open. Community pharmacy contractors can make a claim for a PQS payment up until 11.59pm on Friday 3rd March 2023 through the MYS portal. Contractors must have evidence to demonstrate meeting the gateway criteria and the domains that they have claimed for by the end

    Read more
  • Medicine Supply Notification: Sulfasalazine (Salazopyrin®) 500mg suppositories

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Sulfasalazine (Salazopyrin®) 500mg suppositories. MSN/2023/008 Tier 2 – medium impact Date of issue 3rd February 2023 Sulfasalazine (Salazopyrin®) 500mg suppositories will be out of stock from 6th February until w/c 20th March 2023. Alternative aminosalicylic acid (5-ASA) containing suppositories are available

    Read more
  • Medicine Supply Notification: Imiquimod (Aldara® 5% and Bascellex® 50mg/g) cream

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Imiquimod (Aldara® 5% and Bascellex® 50mg/g) cream. MSN/2023/010 Tier 2 – medium impact Date of issue 3rd February 2023 Imiquimod (Bascellex®) 50mg/g cream is out of stock until early March 2023. Imiquimod (Aldara®) 5% cream is out of stock until mid-

    Read more
  • Medicine Supply Notification: Hyoscine hydrobromide (Kwells Kids®)150mcg and (Kwells®) 300mcg tablets

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Hyoscine hydrobromide (Kwells Kids®)150mcg and (Kwells®) 300mcg tablets MSN/2023/011 Tier 2 – medium impact Date of issue 3rd February 2023 Hyoscine hydrobromide (Kwells Kids®) 150mcg and (Kwells®) 300mcg tablets are out of stock until 15th February 2023. Alternative products remain available

    Read more